Literature DB >> 19209817

Role of tropomyosin in the regulation of contraction in smooth muscle.

Steve Marston1, M El-Mezgueldi.   

Abstract

Smooth muscle contraction is due to the interaction ofmyosin filaments with thin filaments. Thin filaments are composed of actin, tropomyosin, caldesmon and calmodulin in ratios 14:2:1:1. Tissue specific isoforms of act and beta tropomyosin are expressed in smooth muscle. Compared with skeletal muscle tropomyosin, the cooperative activation of actomyosin is enhanced by smooth muscle tropomyosin: cooperative unit size is 10 and the equilibrium between on and off states is shifted towards the on state. The smooth muscle-specific actin-bindingprotein caldesmon, together with calmodulin regulates the activity of the thin filament in response to Ca2+. Caldesmon and calmodulin control the tropomyosin-mediated transition between on and offactivity states.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19209817     DOI: 10.1007/978-0-387-85766-4_9

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  11 in total

Review 1.  Vascular smooth muscle phenotypic diversity and function.

Authors:  Steven A Fisher
Journal:  Physiol Genomics       Date:  2010-08-24       Impact factor: 3.107

2.  Role of thin-filament regulatory proteins in relaxation of colonic smooth muscle contraction.

Authors:  Sita Somara; Robert Gilmont; Khalil N Bitar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-11       Impact factor: 4.052

3.  Tropomyosin variants describe distinct functional subcellular domains in differentiated vascular smooth muscle cells.

Authors:  Cynthia Gallant; Sarah Appel; Philip Graceffa; Paul Leavis; Jim Jung-Ching Lin; Peter W Gunning; Galina Schevzov; Christine Chaponnier; Jon DeGnore; William Lehman; Kathleen G Morgan
Journal:  Am J Physiol Cell Physiol       Date:  2011-02-02       Impact factor: 4.249

4.  Molluscan smooth catch muscle contains calponin but not caldesmon.

Authors:  Anna V Dobrzhanskaya; Ilya G Vyatchin; Stanislav S Lazarev; Oleg S Matusovsky; Nikolay S Shelud'ko
Journal:  J Muscle Res Cell Motil       Date:  2012-10-19       Impact factor: 2.698

5.  Differential effects of thin and thick filament disruption on zebrafish smooth muscle regulatory proteins.

Authors:  G Davuluri; C Seiler; J Abrams; A J Soriano; M Pack
Journal:  Neurogastroenterol Motil       Date:  2010-06-28       Impact factor: 3.598

6.  Noise induced changes in the expression of p38/MAPK signaling proteins in the sensory epithelium of the inner ear.

Authors:  Samson Jamesdaniel; Bohua Hu; Mohammad Habiby Kermany; Haiyan Jiang; Dalian Ding; Donald Coling; Richard Salvi
Journal:  J Proteomics       Date:  2011-08-16       Impact factor: 4.044

7.  Phosphorylated HSP20 modulates the association of thin-filament binding proteins: caldesmon with tropomyosin in colonic smooth muscle.

Authors:  Sita Somara; Robert R Gilmont; Saranyaraajan Varadarajan; Khalil N Bitar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-09-09       Impact factor: 4.052

8.  Amino acid mutations in the caldesmon COOH-terminal functional domain increase force generation in bladder smooth muscle.

Authors:  Maoxian Deng; Ettickan Boopathi; Joseph A Hypolite; Tobias Raabe; Shaohua Chang; Stephen Zderic; Alan J Wein; Samuel Chacko
Journal:  Am J Physiol Renal Physiol       Date:  2013-08-28

9.  ORMDL3 expression in ASM regulates hypertrophy, hyperplasia via TPM1 and TPM4, and contractility.

Authors:  Alexa K Pham; Marina Miller; Peter Rosenthal; Sudipta Das; Ning Weng; Sunghoon Jang; Richard C Kurten; Jana Badrani; Taylor A Doherty; Brian Oliver; David H Broide
Journal:  JCI Insight       Date:  2021-04-08

10.  Molecular mechanical differences between isoforms of contractile actin in the presence of isoforms of smooth muscle tropomyosin.

Authors:  Lennart Hilbert; Genevieve Bates; Horia N Roman; Jenna L Blumenthal; Nedjma B Zitouni; Apolinary Sobieszek; Michael C Mackey; Anne-Marie Lauzon
Journal:  PLoS Comput Biol       Date:  2013-10-24       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.